Healthcare and pharmaceutical industries are under immense pressure. Ageing populations, medical advances and rising patient expectations are fueling demand for their products and services. But budgets are not keeping up with this growing demand or with rising costs.
A recent analysis1 by Deloitte notes that although the world’s major regions are expected to increase spending on healthcare by 2.4% to 7.5% between 2015 and 2020, “infrastructure issues are making it increasingly difficult for public healthcare systems to sustain current levels of service and affordability.” Costs clearly need to be reduced.
1. Deloitte, 2017 global health care sector outlook